Biotech company digitally capturing scent and taste

  • $1,151,650Amount raised
  • $5,000Minimum
  • $15,000,000Valuation cap

Purchased securities are not listed on any exchange. A secondary market for these securities does not currently exist and may never develop. You should not purchase these securities with the expectation that one eventually will.

Aromyx is accepting investments for an Offering under Regulation D through SI Securities, LLC ("SI Securities"). SI Securities is an affiliate of SeedInvest Technology, LLC, a registered broker-dealer, and member FINRA/SIPC. SI Securities will receive cash compensation equal to 7.50% of the value of the securities sold and equity compensation equal to 5.00% of the number of securities sold. This profile may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events based on information currently available and are subject to risks and uncertainties that could cause the company’s actual results to differ materially. Investors are cautioned not to place undue reliance on these forward-looking statements as they are meant for illustrative purposes and they do not represent guarantees of future results, levels of activity, performance, or achievements, all of which cannot be made. Moreover, no person nor any other person or entity assumes responsibility for the accuracy and completeness of forward-looking statements, and is under no duty to update any such statements to conform them to actual results.

Company Highlights

  • Aromyx has signed two multi-million dollar recurring service deals with global companies, with expected revenue of over $5M over three years
  • Aromyx has increased revenue by 83% in 2020 compared to 2019, even in the face of global pandemic (unaudited)
  • Key investors include Ulu Ventures, Radicle Growth, Merus Capital, and CE Ventures
  • Our pricing power continues to grow as the average project revenue and effective price per data point have both doubled each year since 2018
  • Aromyx' patented technology allows us to provide one of the most complete representations of human senses available, with receptors in the nose and tongue

Fundraise Highlights

  • Total Amount Raised: US $1,151,650
  • Total Round Size: US $2,500,000
  • Raise Description:  Bridge
  • Minimum Investment:  US $5,000 per investor
  • Security Type:  Convertible Note
  • Valuation Cap:  US $15,000,000

Aromyx generates unique, quantitative data to objectively connect human perception of taste and smell to products, providing actionable data insights to customers across a range of industries.

The human nose is one of the most sensitive chemical detectors on the planet, yet human reporting is vague and imprecise.  Aromyx uses the same biological receptors from the human nose and tongue to provide a quantitative, reproducible measurement of taste & smell.  

Aromyx connects perception to underlying chemicals and ingredients, providing immediate feedback for reformulation, marketing, or new product design. The biological receptors provide a Rosetta Stone to unify disparate data sets and provide unique, actionable insights to our customers.  These data directly address several multi-billion dollar markets (including food & beverage, pharmaceuticals, and alternative proteins) which have historically used inefficient trial and error approaches for new product development.  

Aromyx has developed a successful Testing-as-a-Service business model which allows us to integrate our data offerings directly into the R&D and marketing departments at large consumer goods companies.  Aromyx initially conducted multiple pilot projects with corporate partners to demonstrate the utility and scope of our unique data to address the customer's issues.  To date, Aromyx has been successful with 100% of our 8+ pilot projects, and all of the pilot customers have engaged and expanded their relationship.  

Aromyx' revenue has grown by over 80% from 2019 to 2020 YTD, even during the Covid shutdown, by both expanding the amount of testing services, but more importantly also continuing to increase the price the customers are willing to pay as they see the value proposition of the data insights.  Two major global companies have now entered into multi-year recurring revenue commitments, and we expect several more to engage in the coming year.

Media Mentions

The Team

Founders and Officers

Josh has 20 years of biotech experience. He led 5 startup companies into commercialization with over $700M in exit values to date.

Josh Silverman


Josh has 20 years of biotech experience. He led 5 startup companies into commercialization with over $700M in exit values to date.

Bill has 20 years of research experience. He is an expert in membrane protein structure and biochemistry.

Bill Harries


Bill has 20 years of research experience. He is an expert in membrane protein structure and biochemistry.

Akshay has 14 years experience as a Wall Street equity research analyst focused on public food & beverage companies.

Akshay Jagdale


Akshay has 14 years experience as a Wall Street equity research analyst focused on public food & beverage companies.

Key Team Members

Fred Stahl

Director, Sales

Morgan Moncada

Director, Operations

Investor Perks

Any investment over $25,000 can receive a one-on-one call with the CEO

It is advised that you consult a tax professional to fully understand any potential tax implications of receiving investor perks before making an investment.

Frequently Asked Questions

Making an Investment in Aromyx
How does investing work?

When you complete your investment on SeedInvest, your money will be transferred to an escrow account where an independent escrow agent will watch over your investment until it is accepted by Aromyx. Once Aromyx accepts your investment, and certain regulatory procedures are completed, your money will be transferred from the escrow account to Aromyx in exchange for your securities. At that point, you will be a proud owner in Aromyx.

What is the difference between preferred equity and a convertible note?

Preferred equity is usually issued to outside investors and carries rights and conditions that are different from that of common stock. For example, preferred equity may include rights that prevent or minimize the effects of dilution or grants special privileges in situations when the company is sold.

A convertible note is a unique form of debt that converts into equity, usually in conjunction with a future financing round. The investor effectively loans money to a startup with the expectation that they will receive equity in the company in the future at a discounted price per share when the company raises its next round of financing.

To learn more about startup investment types check out “How to Choose a Startup Investment” in our academy.

What will I need to complete my investment?

To make an investment, you will need the following information readily available:

  1. Personal information such as your current address and phone number
  2. Employment and employer information
  3. Net worth and income information
  4. Social Security Number or passport
  5. ABA bank routing number and checking account number (typically found on a personal check or bank statement)

Because Aromyx is offering its securities under Rule 506(c) of Regulation D, your status as an Accredited Investor will also need to be verified and you will be asked to provide documentation supporting your income, net worth, revenue, or net assets or a letter from a qualified advisor such as a Registered Investment Advisor, Registered Broker Dealer, Lawyer, or CPA.

What if I change my mind about investing?

Until a closing occurs, you may cancel your investment at any time, for any reason. You will receive an email when the closing occurs and your securities have been issued. If you have already funded your investment and your funds are in escrow, your funds will be promptly refunded to you upon cancellation. To cancel your investment, please go to your portfolio page by clicking your profile icon in the top right corner.

After My Investment
How can I sell my securities in the future?

Currently there is no market or liquidity for these securities. Right now Aromyx does not plan to list these securities on a national exchange or another secondary market. At some point Aromyx may choose to do so, but until then you should plan to hold your investment for a significant period of time before a “liquidation event” occurs. A “liquidation event” is when Aromyx either lists their securities on an exchange, is acquired, or goes bankrupt.

How do I keep track of this investment?

You can return to SeedInvest at any time to view your portfolio of investments and obtain a summary statement.

Other General Questions
What is this page about?

This is Aromyx's fundraising profile page, where you can find information that may be helpful for you to make an investment decision in their company. The information on this page includes the company overview, team bios, and the risks and disclosures related to this investment opportunity.

What are the risks of this investment?

This investment is highly speculative and should not be made by anyone who cannot afford to risk the entire investment amount. In addition to these risks, you should carefully consider the specific information and risks disclosed in Aromyx’s profile.